In 1954, English composer Benjamin Britten and librettist Myfawnwy Piper debuted their own version of the story reshaped as a ...

In the EU, GOHIBIC (vilobelimab) has been granted marketing authorization under exceptional circumstances for the treatment ...

MarkHerz Inc., a biotechnology company specializing in AAV-based gene therapies targeting cardiovascular and metabolic diseases, announced that it has signed a Memorandum of Understanding (MOU) on May ...

The Anaheim Ducks head into the 2025 offseason with $38.69 million in cap space and need to spend $13.79 million to reach the ...

The WisdomTree U.S. LargeCap Fund ETF offers earnings-based exposure, outperforming the S&P 500. Read why I reiterate my Buy ...

A Deep Dive Into the Natural Ingredients, Health Benefits, and Real User Reviews of GlucoTrust's Holistic Blood Sugar Support ...

The acquisition would significantly boost Novartis’ position in rare kidney disease IgA nephropathy (IgAN), which the Swiss big pharma is targeting with oral complement factor B inhibitor ...

Consuming certain spices, such as chili pepper, turmeric, ginger, and cinnamon, may positively affect metabolism and help ...

The factor B inhibitor also allowed significantly more ... with regulators so we can bring this first-in-class alternative complement pathway inhibitor as the first oral monotherapy to people ...

Bring your Tigers football, basketball and recruiting questions, and talk to Eli Hoff in a live chat at 11 a.m. Thursday.

Firetail Resources has increased its gold exposure through an option to acquire two high-grade projects in tier-1 ...